Last reviewed · How we verify
CPT-11 and TS-1
At a glance
| Generic name | CPT-11 and TS-1 |
|---|---|
| Sponsor | Taiho Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer (PHASE2)
- Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer (PHASE2, PHASE3)
- Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |